Wells Fargo & Company »

Aim Immunotech shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $11 4 2.75
2025-06-30 $35 4 8.75

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Aim Immunotech

DRW Holdings
Sabby Management
Vanguard Group
Geode Capital Management
Morgan Stanley
UBS Group
Community Bank
Pnc Financial Services
Advisor Group Holdings
Hoey Investments
Harbour Investments
Wells Fargo & Company
Steward Partners Investment Advisory
Farther Finance Advisors

View all funds holding Aim Immunotech